Skip to main content
Equibles

ARMISTICE CAPITAL, LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 1601086 NEW YORK, NY
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,407,520
-$1,359,200 QoQ
Shares Held
3,398,000
0.0% QoQ
Ownership
4.85%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#3
of 103 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $1,521,563,900 across 51 Biotechnology names. BCYC ranks #27 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDGL
Madrigal Pharmaceuticals, Inc.
 288,000 $154,641,600
2 CYTK
Cytokinetics Inc
 1,201,342 $102,342,324
3 INCY
Incyte Corp
 900,005 $102,024,566
4 TVTX
Travere Therapeutics, Inc.
 1,572,539 $89,335,940
5 AGIO
Agios Pharmaceuticals, Inc.
 2,400,000 $89,064,000
6 PTCT
Ptc Therapeutics, Inc.
 1,071,395 $87,393,690
7 DYN
Dyne Therapeutics, Inc.
 3,087,226 $68,567,289
8 IMVT
Immunovant, Inc.
 1,736,000 $66,888,080

All Filings in BCYC

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,407,520 3,398,000
2026-03-31 $15,766,720 3,398,000
2025-12-31 $22,910,880 3,236,000
2025-09-30 $23,049,720 2,978,000
2025-06-30 $19,460,000 2,800,000
2025-03-31 $22,685,280 2,672,000
2024-12-31 $30,744,000 2,196,000
2024-09-30 $44,264,280 1,956,000
2024-06-30 $39,913,280 1,972,000
2024-03-31 $41,632,800 1,672,000
2023-12-31 $27,770,880 1,536,000
2023-09-30 $20,090,000 1,000,000
2023-06-30 $22,355,520 876,000
2023-03-31 $15,654,720 736,000